Completed OBSERVATIONAL NCT07036809
Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia
Sponsor: Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
Conditions
Acute Leukemia
Updated 2 times since 2025 Last updated: Jan 27, 2026 Started: Jun 1, 2023 Primary completion: Oct 1, 2025 Completion: Oct 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Acute Leukemia and is currently completed. Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Jul 2025 — Feb 2026 [monthly]
Recruiting
First recorded
Jun 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
Data source: Al-Azhar University
For direct contact, visit the study record on ClinicalTrials.gov .